Replies to post #347622 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

I think it is a safe bet that the reclassification came after discussion and approval of the regulators. The same is true of the changes in endpoints.

You are correct in the OLE providing longer term safety data as well as a look at efficacy over a longer time frame.

[boi568]

Keep in mind when discussing the value of an OLE that 2-73 has very little left to prove regarding safety.